Cabot Analyst Price Targets - Benzinga

Cabot Corp

CBTNYSE

Trade with Public

Trade with Public

$72.96

-0.66-0.9%

Ult. Agg.: Oct 21, 11:19 AM

$73.70

0.080.11%

Panoramica Notizie Previsioni utiliObiettivi di prezzoDati finanziari Sentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Cabot Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cabot (CBT).

Price Target Range — 13 Quarters

Analyst Consensus — 5 Analysts

1Buy

3Hold

1Sell

Consensus RatingNeutral# Analysts5Avg. Consensus PT$89Upside to Avg. PT+22.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$92→$86
Aug 7, 2026	JP Morgan	Jeffrey Zekauskas	PT Raise	Underweight	$70→$78
Aug 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$97→$92
Jun 25, 2026	Mizuho	John Roberts	PT Raise	Neutral	$80→$90
Jun 8, 2026	Truist Securities	Peter Osterland	Initiate	Buy	$98
May 13, 2026	JP Morgan	Jeffrey Zekauskas	PT Raise	Underweight	$68→$70
May 8, 2026	UBS	Joshua Spector	PT Raise	Neutral	$81→$86
May 6, 2026	Mizuho	John Roberts	PT Raise	Neutral	$75→$80
Feb 5, 2026	UBS	Joshua Spector	PT Raise	Neutral	$74→$81
Feb 5, 2026	Mizuho	John Roberts	Downgrade	Outperform→Neutral	$80→$75
Jan 12, 2026	UBS	Joshua Spector	PT Raise	Neutral	$65→$74
Dec 18, 2025	Mizuho	John Roberts	PT Raise	Outperform	$72→$80
Nov 28, 2025	JP Morgan	Jeffrey Zekauskas	PT Cut	Underweight	$75→$54
Nov 17, 2025	Mizuho	John Roberts	PT Cut	Outperform	$78→$72
Nov 5, 2025	UBS	Joshua Spector	PT Cut	Neutral	$82→$65
Oct 3, 2025	Mizuho	John Roberts	PT Cut	Outperform	$90→$88
Aug 5, 2025	UBS	Joshua Spector	PT Raise	Neutral	$81→$82
Apr 7, 2025	UBS	Joshua Spector	PT Cut	Neutral	$93→$83
Feb 21, 2025	JP Morgan	Jeffrey Zekauskas	PT Cut	Underweight	$105→$85
Jan 7, 2025	Mizuho	John Roberts	PT Cut	Outperform	$122→$110

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Cabot, Lowers Price Target to $86

UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $92 to $86.

Benzinga Newsdesk

PRO
JP Morgan Maintains Underweight on Cabot, Raises Price Target to $78

JP Morgan analyst Jeffrey Zekauskas maintains Cabot (NYSE:CBT) with a Underweight and raises the price target from $70 to $78.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Cabot, Lowers Price Target to $92

UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $97 to $92.

Benzinga Newsdesk

PRO
Mizuho Maintains Neutral on Cabot, Raises Price Target to $90

Mizuho analyst John Roberts maintains Cabot (NYSE:CBT) with a Neutral and raises the price target from $80 to $90.

Benzinga Newsdesk

PRO
Truist Securities Initiates Coverage On Cabot with Buy Rating, Announces Price Target of $98

Truist Securities analyst Peter Osterland initiates coverage on Cabot (NYSE:CBT) with a Buy rating and announces Price Target of $98.

Benzinga Newsdesk

PRO
JP Morgan Maintains Underweight on Cabot, Raises Price Target to $70

JP Morgan analyst Jeffrey Zekauskas maintains Cabot (NYSE:CBT) with a Underweight and raises the price target from $68 to $70.

Benzinga Newsdesk